Alex Harding

Dr. Alex Harding is an Internal Medicine physician with a robust background in biotechnology.

He obtained his MD from The Johns Hopkins University, a Master of Business Administration (MBA) from Harvard Business School, and a BA in History from Yale University.

Currently, Dr. Harding serves as the Senior Vice President of Business Development and Corporate Strategy at Remix Therapeutics.

He has been a part of various esteemed organizations, including Life Science Cares Boston, Target ALS, Atlas Venture, Massachusetts General Hospital, and ATLAS NEWCO.

With a strong presence in the biotechnology industry, Dr. Harding has also been involved as a Board Observer with companies like Vedere Bio, Triplet Therapeutics, HotSpot Therapeutics, Rodin Therapeutics, and Synlogic, Inc.

His diverse professional journey includes roles as an Entrepreneur In Residence, Senior Director of Corporate and Product Development, Senior Associate, and Associate at different firms in the biotech sector.

Dr. Harding has also contributed his expertise as a Medical Resident at Massachusetts General Hospital, a Founder, Executive Director at Water Ecuador / Aquality International, and an MBA at Harvard Business School.

His educational background, combined with his extensive experience in both medicine and biotechnology, makes him a versatile and well-rounded professional in the field.